nimodipine has been researched along with Cochlear Diseases in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Cochlear Diseases: Pathological processes of the snail-like structure (COCHLEA) of the inner ear (LABYRINTH) which can involve its nervous tissue, blood vessels, or fluid (ENDOLYMPH).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nimodipine treatment did not affect the SP, neither in the control, nor in the EEH ears." | 1.29 | The effect of nimodipine on cochlear potentials and Na+/K(+)-ATPase activity in normal and hydropic cochleas of the albino guinea pig. ( Albers, FW; de Wildt, DJ; Huizing, EH; Klis, SF; Smoorenburg, GF; van Benthem, PP; Veldman, JE, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Benthem, PP | 1 |
| Klis, SF | 1 |
| Albers, FW | 1 |
| de Wildt, DJ | 1 |
| Veldman, JE | 1 |
| Huizing, EH | 1 |
| Smoorenburg, GF | 1 |
1 other study available for nimodipine and Cochlear Diseases
| Article | Year |
|---|---|
The effect of nimodipine on cochlear potentials and Na+/K(+)-ATPase activity in normal and hydropic cochleas of the albino guinea pig.
Topics: Animals; Cochlea; Cochlear Diseases; Cochlear Microphonic Potentials; Endolymph; Endolymphatic Hydro | 1994 |